These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2182938)

  • 1. [Paroxysmal nocturnal hemoglobinuria].
    Blaas P; Weber S; Hänsch GM; Peter HH
    Klin Wochenschr; 1990 Mar; 68(5):247-55. PubMed ID: 2182938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxysmal nocturnal hemoglobinuria. A complement-mediated disease.
    Halperin JA; Nicholson-Weller A
    Complement Inflamm; 1989; 6(1):65-72. PubMed ID: 2650991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM; Schönermark S; Roelcke D
    J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
    Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
    J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Paroxysmal nocturnal hemoglobinuria].
    Caudwell V
    Rev Prat; 1993 Jun; 43(11):1373-8. PubMed ID: 8235386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.
    Risitano AM
    Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxysmal nocturnal hemoglobinuria. Enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane.
    Blaas P; Berger B; Weber S; Peter HH; Hänsch GM
    J Immunol; 1988 May; 140(9):3045-51. PubMed ID: 3361126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunocytochemical staining of decay-accelerating factor (DAF) on erythrocytes: paroxysmal nocturnal hemoglobinuria (PNH)].
    Kobayashi T; Nakazawa M; Sato Y; Tomiyama J; Ninomiya H; Abe T; Terasawa T; Shichishima T; Fujita T
    Rinsho Ketsueki; 1992 Feb; 33(2):162-6. PubMed ID: 1378912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.
    Szer J; Hill A; Weitz IC
    Clin Adv Hematol Oncol; 2012 Nov; 10(11 Suppl 21):1-16. PubMed ID: 23271156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxysmal nocturnal hemoglobinuria (membrane defect, pathogenesis, aplastic anemia, diagnosis).
    Chrobák L
    Acta Medica (Hradec Kralove); 2000; 43(1):3-8. PubMed ID: 10934778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH; Rosenfeld SI; Jenkins DE; Thiem PA; Leddy JP
    J Clin Invest; 1979 Aug; 64(2):428-33. PubMed ID: 457861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards.
    Nilsson B; Hagström U; Englund A; Säfwenberg J
    Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.
    Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5430-4. PubMed ID: 6225118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes. Studies on C9 binding and incorporation into high molecular weight complexes.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Exp Med; 1986 Oct; 164(4):981-97. PubMed ID: 3760783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.
    Lin LI; Chen YC; Lin JK
    Hematology; 1997; 2(5):399-406. PubMed ID: 27405407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal function of CR1 on affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria.
    Roberts WN; Wilson JG; Wong W; Jenkins DE; Fearon DT; Austen KF; Nicholson-Weller A
    J Immunol; 1985 Jan; 134(1):512-7. PubMed ID: 2578050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
    Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
    Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding Complement Therapeutics for the Treatment of Paroxysmal Nocturnal Hemoglobinuria.
    Mastellos DC; Reis ES; Yancopoulou D; Risitano AM; Lambris JD
    Semin Hematol; 2018 Jul; 55(3):167-175. PubMed ID: 30032754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.